Barely Significant
← all phrases

“nominally significant”

7,733 sentences · 7,733 papers · 10,034 search hits before verification · confirmed specimen

Sighted at

p=0.08

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

nominally significantP = 0.0460.9× alphagold
3.5 Sleep disturbance score and rate of brain Aβ accumulation After Bonferroni correction for multiple comparisons, a nominally significant three‐way interaction was observed among moderate/severe sleep disturbance, APOE ε4 carriage, and time (β = 2.35 ± 1.17, P = 0.046), with respect to rate of brain Aβ accumulation.
nominally significantp = 0.0460.9× alphagold
The GGN microsatellite in exon 1 of the AR gene showed modest nominally significant associations between a dichotomous (homozygous major allele GGN 23 carried by 70% of individuals vs rest) measure and two outcomes: child IQ (r = −0.104, p = 0.046) and anxiety symptoms (r = 0.096, p = 0.040).
nominally significantp = 0.0460.9× alphagold
In the fully adjusted model including Total WMH and CMC, standardized β coefficients were −0.005 (95% CI, −0.064 to 0.054; p = 0.87) for reaction time, −0.007 (95% CI, −0.065 to 0.052; p = 0.82) for Trail Making Test–B, −0.058 (95% CI, −0.116 to −0.001; p = 0.046, nominally significant) for fluid intelligence, and −0.019 (95% CI, −0.110 to 0.072; p = 0.68) for digit span.
nominally significantP=0.0460.9× alphagold
Mendelian randomization osteoarthritis dehydroepiandrosterone sulfate estradiol testosterone dihydrotestosterone Causal Association Between Sex Steroid Levels and OA by Sex The nominally significant results of IVW analyses showed that serum DHT level tended to have a causal effect on the risk of OA in women (OR=1.012, 95% CI: 1.000–1.025; P=0.046), while no relationship was observed between sex steroid levels and OA risk in men ( Figure 3 ).
Sex Steroids and Osteoarthritis: A Mendelian Randomization Study.
Front Endocrinol (Lausanne) · 2021 · PMC8261132
nominally significantP = 0.0460.9× alphagold
The P ‐value for the interaction of prior HF was nominally significant ( P = 0.046); however, this was not controlled for multiple comparisons. 3.4 Time to first occurrence of MACE in the phase 3a glycaemic efficacy trials In the combined SUSTAIN and PIONEER glycaemic efficacy trials, the incidence rates for MACE were 0.7 and 0.9 events per 100 subject‐years with semaglutide and comparator, respectively (HR 0.85 [95% CI 0.55, 1.33]; Figure 4 ).
nominally significantp = 0.0460.9× alphagold
For ΔDSL, the interaction term was nominally significant (β = −0.605, 95% CI −1.198 to −0.012; p = 0.046); because this analysis was exploratory and the study was not powered for interaction testing, this finding was interpreted cautiously and not taken as evidence of a confirmed modifying effect.
nominally significantp = 0.0460.9× alphagold
Subsequently, we used a t ‐test to compare the ME between AD+P and AD−P samples, identifying six nominally significant modules (darkgreen: N = 1023 probes, p = 0.046; firebrick4: N = 122 probes, p = 0.025; darkseagreen3: N = 105 probes, p = .012; magenta: N = 6368 probes, p = 0.030; grey60: N = 1830, p = 0.018; greenyellow: N = 5512 probes, p = 0.045).
nominally significantp = 0.04690.9× alphagold
Changes in airway volume were generally consistent across lobes for both treatments; however, the untransformed analysis of untrimmed iVaw by airway generation showed a nominally significant interaction between treatment and generation ( p = 0.0469), indicating potential differences in the effects of GP MDI and FF MDI by generation ( Figure 3(a) ).
nominally significantP ≈ 0.0470.9× alphagold
Notably, several KEGG “disease” or host-associated annotation categories (e.g., toxoplasmosis, small cell lung cancer, p53 signaling, influenza A, viral myocarditis, colorectal cancer) appeared among nominally significant features (all P ≈ 0.047) but displayed effect sizes close to zero.